ArticleAAPS PharmSciTech2025

Co-amorphous Approach for Enhancing Rilpivirine Oral Bioavailability using CYP3A4 Inhibitor as a Co-former.

Ashwini R Madgulkar et al.PubMed ↗Publisher ↗

No numbers read from the abstract.